Allez M, Sands BE, Feagan BG, D'Haens G, et al. A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients With Moderately to Severely Active Crohn's Disease. J Crohns Colitis 2023 Mar 20:jjad047. doi: 10.1093.
PMID: 36939629